C[S+](CCC(N)C(=O)O)[C@@H](O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)C[C@@H]1O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?